Clinical Trials Browser

Phase 1 × Malignant Solid Neoplasm × veliparib × Clear all

NCT02631733 2025-02-10

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Malignant Solid Neoplasm